Director of General Surgery Research, Associate Professor, Department of Surgery
Doctor of Philosophy in Chemical Engineering, May 1999. Joint Biochemical Engineering program between the College of Engineering (Chemical Engineering) and the School of Medicine (Developmental Biology and Anatomy)
The University of South Carolina, Columbia, South Carolina 29208
Thesis: Design and Analysis of a Mechanical Cell Stimulator. Advisors: Dr. Louis Terracio PhD (Medicine) and Dr. Harry J. Ploehn PhD (Engineering)
Master of Science in Chemical Engineering, June 1990.
Ohio University, Athens, Ohio 45701
Thesis: Modeling a Semi-batch Reactor Using a Neural-Network. Advisor: Dr. Kenneth Sampson PhD.
Bachelor of Science in Chemical Engineering, June 1985.
The Ohio State University, Columbus, Ohio 43210
Medical University of South Carolina Charleston, South Carolina 29425 January 2012- Present
Director of General Surgery Research, Associate Professor, Department of Surgery
Appointments in Department of Surgery, Department of Regenerative Medicine and Clemson University Department of Bioengineering.
Responsible for all facets of the research effort in the Department of Surgery Division of General Surgery and Acute Care including: recruitment, personnel management, budget management and control, scientific direction, funding procurement, intellectual property identification and patent development, negotiations and presentations with potential licensors of intellectual property, and management of multiple collaborative efforts within the University and other institutions and businesses.
University of South Carolina School of Medicine January 2000 –January 2012
Columbia, South Carolina 29208
Appointments in Department of Surgery, Chemical Engineering, and Cell Biology and Anatomy.
Associate Professor of Surgery February 2009-January 2012
Director of Surgical Research January 2003 – January 2012
Responsible for all facets of the research effort in the Department of Surgery including: recruitment, personnel management, budget management and control, scientific direction, funding procurement, intellectual property identification and patent development, negotiations and presentations with potential licensors of intellectual property, and management of multiple collaborative efforts within the University and other institutions and businesses.
· Invented and developed a new extrusion device for producing collagen based tissue engineering scaffolds. Device provides more in vivo like orientation to the scaffold fibers.
· Co- inventor of a novel resuscitative fluid to treat severe hypovolemia.
· Co-inventor of a novel method for determining resuscitation endpoint.
· Secured several multi-year funding grants from government and other public institutions as PI or as co- investigator in collaborative efforts.
Research Assistant Professor of Surgery January 2000- January 2003
Responsible for resident research training and the establishment of a research program within the Department of Surgery where none existed. Transition from Industrial engineering to academic training responsibilities.
Vitasol LLC Dec 2007 to present
Lexington SC 29072
Vice Chairman and Secretary,Vitasol Inc. November 2008 to present.
Vitasol LLC is a biotech startup company that specializes in novel resuscitative fluids and strategies. Responsible for raising capital funds, supervision of scientific experimentation, creation of business plans and overall company operation.
Managing Partner Vitasol LLC Dec 2007 to 2008.
Devro-Teepak, Inc. May 1991 – January 2000
PO Box 11925, Columbia, South Carolina, 29211
Process Development & Engineering Manager June 1998 – January 2000.
Responsible for ten professional and nine hourly employees, development laboratory, and pilot plant. Responsible for management of a capital investment budget of $1,500k annually.
· Lead and completed the conception, development and installation of a $6,000k new technology process developed by our group. The new process produces products that serve an existing market at a 30% lower cost of manufacture (new technology installation).
· Redesigned glutaraldehyde treatment system to reduce process variability by 60%.
Process Development Manager June 1996 - June 1998
Responsible for a ten person research and development department. The department develops and evaluates new technology and new processes for the production of collagen based food casings consistent with Devro-Teepak business objectives.
R&D Group Leader January 1993 - June 1996
Responsible for a five-person research and development department for the production of collagen food casings.
Highlight:Developed a new product and process to produce collagen food casings to compete in the UK market.
Senior Development Engineer January 1992 - January 1993
Responsible for research project execution. Directed the activities of research technicians assigned to the project.
Highlight:Developed a new dryer design that is 50% more efficient than previous technology.
Development Engineer May 1991 - January 1992
Responsible for research project execution. Directed the activities of research technicians assigned to the project.
American Cyanamid Co. 1985 - 1991
Chemical Research Center, 1937 West Main St., Stamford, Connecticut 06904
Applications Engineer December 1990 - May 1991
Responsible for new product and process development, and customer technical service.
Willow Island Plant, Willow Island, West Virginia
Technical Specialist April 1988 - December 1990
Responsible for production technical support, new process development, quality management system, and environmental reporting for an eight million-lb./yr. isocyanate plant. Member of a team responsible for evaluation of toll manufacturers to produce scale up quantities of new urethane products.
Highlights: Developed a new batch process to produce polyurethane aqueous dispersions. Developed the process and produced the product four months ahead of schedule for 50% of the original cost estimate.
Process Engineer April 1986 - April 1988
Key member of the engineering team involved in the design, construction, and startup of a computer controlled multimillion dollar isocyanate plant.
· Computer modeling of a reactor system resulted in a yield improvement of 18% and a waste reduction and cost savings of approximately $750,000 per year.
· Worked as technical advisor for a new product production trial at Takeda Chemical Shimizu, Japan. The trial successfully produced commercial quantities of the new product for test marketing.
Pilot Plant Shift Leader July 1985 - April 1986
Shift leader of a pilot plant crew, responsible for supervision of pilot plant operations, maintenance, and reporting on plant performance.
1. Hong Tan, Ph.D.; Stefanie Biechler; Lorain Junor; Michael J
Yost, Ph.D.; Delphine Dean, Ph.D.; Jinqing Li, Ph.D.; Jay D Potts, and Richard Goodwin, Fluid flow forces and rhoA regulate fibrous development of the atrioventricular valves Corresponding. Developmental Dynamics, In Press. 2012.
2. Oliveira SM, Ringshia RA, Legeros RZ, Clark E, Yost MJ, Terracio L, Teixeira CC. An improved collagen scaffold for skeletal regeneration. J Biomed Mater Res A. 2010 Aug; 94(2):371-9.
3. Amos JR, Li S, Yost M, Phloen H, Potts JD. Limb bud mesenchyme cultured under tensile strain remodel collagen type I tubes to produce fibrillar collagen type II. Biorheology. 2009 Jan;46(6):439-50.
5. Valarmathi MT, Goodwin RL, Fuseler JW, Davis JM, Yost MJ, Potts JD. A 3-D cardiac muscle construct for exploring adult marrow stem cell based myocardial regeneration. Biomaterials. 2010 Apr;31(12):3185-200. Epub 2010 Feb 2.
6. Biechler SV, Potts JD, Yost MJ, Junor L, Goodwin RL, Weidner JW. Mathematical modeling of flow-generated forces in an in vitro system of cardiac valve development. Ann Biomed Eng. 2010 Jan;38(1):109-17. Epub 2009 Oct 28.
7. Logan MS, Propst JT, Nottingham JM, Carpenter, CL, Goodwin RL, Terracio L, Yost MJ, Fann SA. Human Satellite Progenitor Cells for use in Myofascial Repair: Isolation and Characterization. Annals of Plastic Surgery, June, 2010.
8. Propst JT, Terracio L, Fann SA, Yost MJ. The Role of Wound Healing and Inflammatory Mediators: Integration of Implanted Engineered Myofascial Constructs. Submitted: J. Of Investigative Surgery. April, 2009.
9. Propst JT, Thiruvanamalai V, Goodwin RL, Lessner SM, Soder BL, Terracio L, Fann SA, Yost MJ. In vivo Investigation of Angiogenesis within Implanted Engineered Skeletal Muscle Tissue Grafts. In revision. Submitted: J. Of Investigative Surgery. Feb 2009.
10. Morrison JE, Brizendine JB, Yost MJ, Fann SA., Massive ventral hernia with extensive heterotopic ossification: the honeycomb-abdomen. J Trauma. 2009 Apr; 66(4):1234-7.
11. Norris RA, Potts JD, Yost MJ, Junor L, Brooks T, Tan H, Hoffman S, Hart MM, Kern MJ, Damon B, Markwald RR, Goodwin RL. Periostin promotes a fibroblastic lineage pathway in atrioventricular valve progenitor cells. Dev Dyn. 2009 Mar 30.
13. Nesbitt TL, Roberts A, Tan H, Junor L, Yost MJ, Potts JD, Dettman RW, Goodwin RL. Coronary endothelial proliferation and morphogenesis are regulated by a VEGF-mediated pathway. Dev Dyn. 2009 Feb; 238(2):423-30.
14. A three-dimensional model of vasculogenesis. Valarmathi MT, Davis JM, Yost MJ, Goodwin RL, Potts JD.Biomaterials. 2009 Feb; 30(6):1098-112.
15. Propst, John T., Fann, Stephen A., Franchini, Jessica L., Hansen, Karyn J. , Lessner, Susan M., Rose, John R., Terracio, Louis and Yost, Michael J. “Focused in vivo Genomic Analysis of Implanted Engineered Myofascial Constructs.” Journal of Investigative Surgery, Feb, 2009.
16. Chaudry, W., Ashton, H., Muhamed A., Yost, MJ., Bull, S., and Daniel Frankel. Nanoscale viscoelastic properties of an aligned collagen scaffold. J Mater Sci: Mater Med DOI 10.1007/s10856-008-3574-3. Aug 2008.
17. Propst, John T., Fann, Stephen A., Franchini, Jessica L., Hansen, Karyn J. , Lessner, Susan M., Rose, John R., Terracio, Louis and Yost, Michael J. “Focused in vivo Genomic Analysis of Implanted Engineered Myofascial Constructs.” Accepted Journal of Investigative Surgery, 2008.
18. Propst, JT, Hansen, KJ, Yost, MJ, Morrison JE, and Fann, SA. “Unique Recalcitrant Hernia Repair: Enterocutaneous Fistula with Complex Ventral Hernia.” Accepted American Surgeon. January 2008.
19. Valarmathi MT, Yost MJ, Goodwin RL, Potts JD. A three-dimensional tubular scaffold that modulates the osteogenic and vasculogenic differentiation of rat bone marrow stromal cells. Tissue Eng Part A. 2008 Apr; class="volume"14( class="issue"4): class="pages"491-504.
20. Valarmathi MT, Yost MJ, Goodwin RL, Potts JD. The influence of proepicardial cells on the osteogenic potential of marrow stromal cells in a three-dimensional tubular scaffold. Biomaterials. 2008 May; class="volume"29( class="issue"14): class="pages"2203-16. Epub 2008 Mar 4.
21. Rhett JM, Ghatnekar GS, Palatinus JA, Michael OQuinn M, Yost MJ, Gourdie RG. Novel therapies for scar reduction and regenerative healing of skin wounds. Trends Biotechnol. 2008 Apr; class="volume"26( class="issue"4): class="pages"173-80. Epub 2008 Mar 4. Review.
22. Potts, JD, MJ Yost, G. Kaur, Q. Wang, T Valarmathi. A Tubular Scaffold that Modualtes differentiation of Rat Bone Marrow Stem Cells. Microscopy and Microanal 14(Suppl 2), 2008.
23. Yan W, George S, Fotadar U, Tyhovych N, Kamer A, Yost MJ, Price RL, Haggart CR, Holmes JW, Terracio L. Tissue Engineering of Skeletal Muscle. Tissue Eng. 2007 Sep 19.
24. Sutton MA, Ke X, Lessner SM, Goldbach M, Yost M, Zhao F, Schreier HW., Strain field measurements on mouse carotid arteries using microscopic three-dimensional digital image correlation. J Biomed Mater Res A. 2007 Jul 2;
25. Nesbitt, TL, PA Patel, MJ Yost, RL Goodwin, and JD Potts. A 3-D Model of Coronary Vessel Development. In Vitro CellDev.Biol-Animal 43:10-16. 2007.
26. Potts, JD, T. Nesbitt, MJ Yost, and Richard Goodwin. Using Confocal Microscopy to Explore Cardiac Development and Disease. Microsc Microanal 13(Suppl 2), 2007.
27. Franchini J, Cromer, G, Propst, J, and Yost, MJ. Novel Tissue Engineered Tubular Heart Tissue for in vitro Pharmaceutical Toxicity Testing Microsc Microanal. 2007 Aug;13(4):267-71.
28. Friedman, HI, Giurgiutiu V., Bender, J., Crachiolo, G. and Yost, MJ. " A biomechanical and morphologic analysis of capsule formation around implanted piezoelectric wafer active sensors in rats treated with cyclooxygenase-2 inhibition. Ann Plast Surg. 2008 Feb;60(2):198-203
29. Wang, Xinnan, Yongda Yan, Michael J Yost, Stephen A Fann, Shen Dong and Xiaodong Li Nanomechanical Characterization of Micro/nanofiber Reinforced Type I Collagens J Biomed Mater Res A. 2007 Mar 23; [Epub ahead of print].
31. Nesbitt, T, A Lemley, J Davis, M J Yost, RL Goodwin, Jay D. Potts. Epicardial Development in the Rat: A New Perspective. Microscopy and Microanalysis. 2006 Oct;12(5):390-8.
32. SA Fann, Kosciusko, RD, Yost, MJ, Brizendine, JB, Blevins, WA, Sixta, SL, Morrison, JE, and Bynoe, RD. Use of Prognostic Indicators in the Development of a Statistical Model Predictive for Adrenal Insufficiency in Trauma Patients. Am Surg. 2007 Mar;73(3):210-4.
33. Morrison, JE, JB Brizendine, MJ Yost, and SA Fann. Massive Ventral Hernia with Extensive Heterotopic Ossification: The Honeycomb Abdomen. Accepted Journal of Trauma-Injury Infection & Critical Care. April 2006.
34. Brizendine, JB, JF LeFaivre, MJ Yost, and SA Fann. Reconstruction of a Parasacral Hernia with Acellular Human Dermis Graft. Hernia. 2006 Aug;10(4):360-3.
35. Sweitzer, SM, SA Fann, TK Borg, JW Baynes, and MJ Yost. What is the Future of Diabetic Wound Care? Diabetes Educator. March/April 32 (2), 2006;197:210.
36. Fann, SA, JL Franchini, L.Terracio, and Yost, MJ. A Model of Tissue Engineered Ventral Hernia Repair. J Invest Surg. 2006 May-Jun;19(3):193-205.
37. Potts, JD, MJ Yost, RL Goodwin. Models of Cardiovascular Development: New Approaches are Making In Vitro En Vogue. Curr. Card Reviews. December 2005.
38. Bender JW, Friedman HI, Giurgiutiu V, Watson C, Fitzmaurice M, and Yost MJ. The Use of Biomedical Sensors to Monitor Capsule Formation Around Soft Tissue Implants. Ann Plast Surg. 2006 Jan;56(1):72-77
39. Wang, X., X. Li, and M. J. Yost Microtensile Testing of Collagen Fibrils for Cardiovascular Tissue Engineering, J Biomed Mater Res A. 2005 Aug 1;74(2):263-8.
40. Yost, MJ, JL Franchini, RL Goodwin, T Nesbitt and J Potts, Tissue Engineered Heart Tube Using Embryonic Tissues, Microsc Microanal 11(Suppl 2), 2005.
41. Yan, W, MJ Yost, RL Price, U Fotadar, S. George, L Terracio, Cell-Cell interaction in Engineered Cardiac Tissue, Microsc Microanal 11(Suppl 2), 2005.
42. Yan, W., U. Fotadar, S. George, MJ Yost, R. L. Price, L. Terracio, Tissue Engineering of Skeletal Muscle, Microsc Microanal 11(Suppl 2), 2005.
43. Potts, JD, C Wells, N. Turnipseed, T. Nesbitt, MJ Yost, RL Goodwin. Novel Approaches to the Study of cardiovascular Development. Microsc Microanal 11(Suppl 2), 2005.
44. Goodwin, RL, T Nesbitt, RL Price, JC Wells, MJ Yost and JD Potts. 2004. A Three-Dimensional Model of Valvulogenesis. 2005 May;233(1):122-9.
45. Joel Atance, MJ Yost, W. Carver Influence of the extracellular matrix on the regulation of cardiac fibroblast behavior by mechanical stretch (p NA). J Cell Physiol. 2004 Sep;200(3):377-86.
46. Boughey JC, MJ Yost, RP Bynoe Diabetes insipidus in the head-injured patient. Am Surg. 2004 Jun;70(6):500-3.
47. Victor Giurgiutiu, Harold Friedman, Jonathan Bender, Thomas Borg, Michael J. Yost, William Newcomb, Amanda Black, Joel Bost, Christopher D. Stewart Electromechanical Impedance Sensor for In Vivo Monitoring the Body Reaction to Implants. J. of Investigative Surgery. September 2004.
48. Friedman, H, C. Stonerock, and M. J. Yost. Use of Seprafilm® and INTERCEED® as a Barrier Film to Prevent Capsule Contracture. J. of Investigative Surgery. September 2004.
49. Yost, Michael J., C. F. Baicu, C. E. Stonerock, R. L. Goodwin, R. L. Price, J. M. Davis, H. Evans, P. D. Watson, C. M. Gore, J. Sweet , L. Creech, M. R. Zile, and L. Terracio, A Novel Tubular Scaffold for Cardiovascular Tissue Engineering. Tissue Engineering Vol. 10, 1/2 pp. 273-84, 2004.
50. Evans, HJ, JK Sweet, RL Price, MJ Yost, and RL Goodwin. A novel 3-D Culture System for the Study of Cardiac Myocyte Development. Microsc Microanal 10(Suppl 2), 2004.
52. Young HE, Duplaa C, Yost MJ, Henson NL, Floyd JA, Detmer K, Thompson AJ, Powell SW, Gamblin TC, Kizziah K, Holland BJ, Boev A, Van De Water JM, Godbee DC, Jackson S, Rimando M, Edwards CR, Wu E, Cawley C, Edwards PD, Macgregor A, Bozof R, Thompson TM, Petro GJ Jr, Shelton HM, McCampbell BL, Mills JC, Flynt FL, Steele TA, Kearney M, Kirincich-Greathead A, Hardy W, Young PR, Amin AV, Williams RS, Horton MM, McGuinn S, Hawkins KC, Ericson K, Terracio L, Moreau C, Hixson D, Tobin BW, Hudson J, Bowyer FP 3rd, Black AC Jr. Clonogenic analysis reveals reserve stem cells in postnatal mammals. II. Pluripotent epiblastic-like stem cells. Anat Rec A Discov Mol Cell Evol Biol. 2004 Mar;277(1):178-203.
53. Henry E. Young,*, Cecile Duplaa, Marina Romero-Ramos, Marie-Francoise Chesselet, Patrick Vourc’h, Michael J. Yost, Kurt Ericson, Louis Terracio, Takayuki Asahara, Haruchika Masuda, Sayaka Tamura-Ninomiya, Kristina Detmer, Robert A. Bray, Timothy A. Steele, Douglas Hixson, Mohammad el-Kalay, Brian W. Tobin, Roy D. Russ, Michael N. Horst, Julie A. Floyd, Nicholas L. Henson, Kristina C. Hawkins, Jaime Groom, Amar Parikh, Lisa Blake, Laura J. Bland, Angela J. Thompson, Amy Kirincich, Catherine Moreau, John Hudson, Frank P. Bowyer III, T. J. Lin, and Asa C. Black Jr. Adult Reserve Stem Cells and Their Potential for Tissue Engineering Cell Biochemistry Biophysics, volume 40, pages 1-80, 2004.
54. Boughey, J. C., C. J. Ewart, M.J. Yost, J. M. Nottingham, J. J. Brown. Chloride/Phosphate Ratio in Primary Hyperparathyroidism. The American Surgeon. 70(1): 25-28, Jan. 2004
55. Stonerock CE. Bynoe RP. Yost MJ. Nottingham JM. Use of a vacuum-assisted device to facilitate abdominal closure. American Surgeon. 69(12):1030-4; discussion 1034-5, Dec. 2003
57. Evans HJ.Sweet JK.Price RL.Yost M.Goodwin RL. Novel 3D culture system for study of cardiac myocyte development. American Journal of Physiology - Heart & Circulatory Physiology. 285(2):H570-8, 2003 Aug.
58. Bynoe RP. Kerwin AJ. Parker HH 3rd. Nottingham JM. Bell RM. Yost MJ. Close TC. Hudson ER. Sheridan DJ. Wade MD. Maxillofacial injuries and life-threatening hemorrhage: treatment with transcatheter arterial embolization. Journal of Trauma-Injury Infection & Critical Care. 55(1):74-9, 2003 Jul.
59. Erickson, K., Nottingham, J. Yost, M. J., Primary Treatment of Pleural Effusions: VATS Poudrage Versus Tube Thoracostomy., American Surgeon. Vol. 68 (11), 2002 Nov.
60. Parker, H., Nottingham, J., Yost, M. J., Bynoe, R. Laparoscopic Repair of Incisional Hernias., American Surgeon. Vol. 68 (6), pp 530-534, June 2002.
61. Yost, M.J., R. L. Price, D. G. Simpson, and L. Terracio. Artifical Myocardium: Design Principles and Substratum. Microscopy and Microanalysis. 7 (suppl 2): pp. 138-139. 2001.
62. Yost M. J., D. G. Simpson, K. Wrona, S. Ridley, H. Ploehn, T. Borg, L. Terracio. Design and Construction of a Uniaxial Cell Stretcher., American Journal of Physiology, Heart and Circulatory Physiology., 279:H3124-H3130. 2000 Dec.
1. Michael J. Yost, Mary O. Morales, Veronica Rodriguez-Rivera and Louis Terracio Methods for the Isolation, Purification and Culture of Primary Skeletal Muscle Satellite Cells In: Wound Regeneration and Repair, Methods and Molecular Biology, ed. Robert Gourdie, in press, 2012.
2. Stephen A. Fann, Mary O. Morales, Veronica Rodriguez-Rivera, Eric M. Yost, and Michael J. Yost, A Model System for Primary Abdominal Closures In: Wound Regeneration and Repair, Methods and Molecular Biology, ed. Robert Gourdie, in press, 2012.
3. Ongstad E, Yost MJ, Goodwin RL, Friedman HI, Fann SA, Ghatnekar GS Gourdie RG. Regenerative Pharmacology of Implanted Materials and Tissue Engineered Constructs. In: Regenerative Pharmacology, (eds George Christ, Anthony Atala), in press.
4. Ongstad EL, O’Quinn MP, Ghatnekar G, Yost MJ, Gourdie RG. A connexin43 mimetic peptide promotes regenerative healing and improves mechanical properties in skin and heart. Wound Repair and Regeneration, in press, 2011
5. Price, RL, J Davis, MJ Yost, RL Goodwin, L Terracio. 2004. Electron Microscopy: It’s role in Imaging of Biomaterials and Engineered Cells and Tissues. In Encyclopedia of Biomaterials and Biomedical Engineering. G. Wnek and G. Bowin (eds). Marcel Dekker. Inc. pp534-542.
6. Yost, M. J., Terracio, L, Price, R. L., Collagen Processing in Encyclopedia of Biomaterials and Biomedical Engineering. G. Wenek and G. Bowlin Editors; Marcel Dekker, Inc. 2004.
8. Yost, M. J., Price, R. L., Simpson D. G., Yan, W., and Terracio, L. Cardiac Tissue Engineering in Encyclopedia of Biomaterials and Biomedical Engineering; G. Wenek and G. Bowlin Editors; Marcel Dekker, New York 2002.
1. U.S. Patent No. 7,338,517. Issued 2007. Tissue Scaffold having Aligned Fibrils, Apparatus and Method for Producing same, and Artificial Tissue and Methods of Use Thereof.
2. Canada patent No. 2,528,134 Tissue scaffold having aligned fibrils, apparatus and method for producing the same, and artificial tissue and methods of use thereof.
3. 12/072,150 Divisonal 1. Tissue scaffold having aligned fibrils, apparatus and method for producing the same, and artificial tissue and methods of use thereof.
4. US Patent No. 7,727,441 Divisional 2. Tissue scaffold having aligned fibrils, apparatus and method for producing the same, and artificial tissue and methods of use thereof.
5. 12/072,232 Divisonal 3. Tissue scaffold having aligned fibrils, apparatus and method for producing the same, and artificial tissue and methods of use thereof.
6. US Patent No. 7,754,247 Novel Resuscitative Fluid.
7. 12/722,915 Novel Resuscitative Fluid.
8. Australia patent No. 20082605588 Novel Resuscitative Fluid.
9. Europe Patent No. 08767894.2 Novel Resuscitative Fluid.
The goal of this project is to develop the technology to engineer skeletal muscle.
K25 NIH-NHLBI HL67097 Michael J. Yost (PI) $630,000 2001-2007
Mentored Quantitative Research Career Development Award
Mentor: Louis Terracio Ph. D.
Overall Goals: The goal of project is to transition my career from a practicing industrial engineering manager to a practicing Biomedical research engineer. Further, the research goal of this project is to develop an artificial myocardium patch.
The goal of this project was to create a linear artificial heart tube.
“Bacterial Immobilization.” Funded by Adhezion Biomedical. 2006
ECHE/BMEN 320 Introduction to Fluid Mechanics. 2010 to present
Cardiovascular Disease. Course Director Wayne Carver. Lectures include: Cardiovascular Physiology, Cardiovascular Disease, and Engineering Solutions to Cardiovascular Problems. 2005 to present.
ECHE 589B: Topics in Biomedical Engineering. Course Director Jonathan Bender. Lectures include: Cardiovascular Physiology, Cardiovascular Disease, and Engineering Solutions to Cardiovascular Problems. 2006 and 2007.
Laboratory: Suturing and Knot tying. Course Director Michael J Yost PhD. 2006 to present.
Associate Editor for Biomaterials Journal “Titanium” January 2008 to present
Editorial Board for “Annals of Plastic Surgery” December 2009 to2011
Reviewer for the following Journals:
Microscopy and Microanalysis
American Journal of Physiology
Biomedical Materials Research
Annals of Plastic Surgery
2007 to present Consultant to Organogenesis Inc. Specifically on Biomaterials and Collagen processing.
2008 to present Consultant to Devro-Teepak Inc. Specifically on the Proper treatment and processing of collagen.
GRADUATE STUDENTS AND RESEARCH FELLOWS TRAINED:
Resident Research Fellows
Kurt Erikson, MD 2001-2002
Charles Stonerock, MD 2002-2003
Stephen Fann, MD 2002-2003
Scott Silver, MD 2003-2004
Judy Boughey, MD 2003-2004
William Newcomb, MD 2004-2005
Christopher Watson, MD 2005-2006
Brian Brizendine, MD 2006-2007
Sonny Jones, MD 2007-2008
Melissa Logan, MD 2007-2008
Diego Pabon-Romero, MD 2008-2009
Joel Bradley MD 2009-2010
Veronica Rodriguez (PhD chemicalengineering) Current student projected graduation May 2013.
John Propst (PhD/MBA) PhD Dec 2008, MBA May 2010. Biomedical Science/ Masters Business Administration. Newton Award for Graduate student Research, 2nd Place award USC Graduate Student Day research competition
Brent Soder MS. Biomedical Science 2008. Currently medical student Medical University of South Carolina